Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

A-007

Supelco

(±)-Amphetamin -Lösung

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Synonym(e):

(±)-Amphetamin -Lösung

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C9H13N
CAS-Nummer:
300-62-9
Molekulargewicht:
135.21
MDL-Nummer:
MFCD00056185
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329770569
NACRES:
NA.24

Qualität

certified reference material

Form

liquid

Leistungsmerkmale

SNAP-N-SPIKE®. SNAP-N-SHOOT®

Verpackung

ampule of 1 mL

Hersteller/Markenname

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)

Konzentration

1.0 mg/mL in methanol

Methode(n)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Anwendung(en)

forensics and toxicology

Format

single component solution

Lagertemp.

−20°C

SMILES String

CC(N)Cc1ccccc1

InChI

1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3

InChIKey

KWTSXDURSIMDCE-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

Amphetamine, a stimulant of the phenethylamine class, is found in ADHD-treatment drugs such as Adderall®, Vyvanse®, and ProCentra®. Because of its stimulant effect, amphetamine is used recreationally as a performance-enhancer and illicit drug. This Certified Spiking Solution® is applicable for use in urine drug testing, sports testing, clinical toxicology, or forensic analysis applications by LC-MS/MS or GC/MS.

Anwendung

  • The research utilizes amphetamine as a model compound to validate new toxicological screening methods, improving postmortem diagnostic processes and forensic investigations (Franzin et al., 2024).
  • The study Investigates innovative sample preparation technologies for detecting amphetamines in biological matrices, pushing forward the capabilities in toxicological analysis and monitoring (Fabris et al., 2024).

Rechtliche Hinweise

Adderall is a registered trademark of Richwood Pharmaceutical Company, Inc.
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
ProCentra is a registered trademark of Outlook Pharmaceuticals, Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Vyvanse is a registered trademark of Shire, LLC

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

A-016

(±)-Amphetamin-d11 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-050

Amin-Mischung 6 -Lösung, 250 μg/mL each component in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-002

(±)-Amphetamin-d5 (Deuterium-Markierung am Ring) -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-005

(±)-Amphetamin-d5 (Deuterium-Markierung an der Seitenkette) -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-008

S(+)-Amphetamin (Dextro-Amphetamin) -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-013

(±)-Amphetamin-d5 (Deuterium-Markierung an der Seitenkette) -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-017

(±)-Amphetamin-d8 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-018

(±)-Amphetamin-d8 -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-019

(±)-Amphetamin-d11 -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-044

(±)-Amphetamin-d6 -Lösung, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-045

(±)-Amphetamin-d6 -Lösung, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-049

R(-)-Amphetamin (Levo-Amphetamin), 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

E-018

(±)-N-Ethylamphetamine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

L-026

Lisdexamfetamine dimesylate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

L-028

Lisdexamfetamin-D4 Dimesylat -Lösung, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

P-050

PMA -hydrochlorid -Lösung, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

A-212

(±)-Amphetamine-13C6 hydrochloride solution, 100 μg/mL in methanol ((as free base)), certified reference material, ampule of 1 mL, Cerilliant®

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Zielorgane

Eyes,Central nervous system

Lagerklassenschlüssel

3 - Flammable liquids

WGK

WGK 2

Flammpunkt (°F)

49.5 °F - closed cup

Flammpunkt (°C)

9.7 °C - closed cup

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 4

1 of 4

Phentermin -Lösung 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

P-023

Phentermin -Lösung

(±)-MDEA -Lösung 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

M-065

(±)-MDEA -Lösung

(±)-Methamphetamin-D11 -Lösung 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

M-060

(±)-Methamphetamin-D11 -Lösung

Morphin -Lösung 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

M-005

Morphin -Lösung

Emily E Reichard et al.
Pharmaceutical research, 33(12), 2954-2966 (2016-11-04)
Methamphetamine (METH) abuse is a worldwide drug problem, yet no FDA-approved pharmacological treatments are available for METH abuse. Therefore, we produced an anti-METH single chain antibody fragment (scFv7F9Cys) as a pharmacological treatment for METH abuse. ScFv's have a short half-life
John F Bowyer et al.
BMC genomics, 14, 147-147 (2013-03-19)
The meninges (arachnoid and pial membranes) and associated vasculature (MAV) and choroid plexus are important in maintaining cerebrospinal fluid (CSF) generation and flow. MAV vasculature was previously observed to be adversely affected by environmentally-induced hyperthermia (EIH) and more so by
Constraints on regulatory options for putatively cognitive enhancing drugs.
Wayne Hall et al.
The American journal of bioethics : AJOB, 13(7), 35-37 (2013-06-19)
The indirect psychological costs of cognitive enhancement.
Nadira Faulmüller et al.
The American journal of bioethics : AJOB, 13(7), 45-47 (2013-06-19)
Enhancement policy and the value of information.
Anders Sandberg
The American journal of bioethics : AJOB, 13(7), 34-35 (2013-06-19)
Alle zugehörigen Dokumente anzeigen

Protokolle

Accurate Biological Testing for Amphetamine and Methamphetamine Abuse Using Chiral HPLC and MS Detection

Optimized sample prep and chiral chromatography methods for the LC/MS analysis of these drug enantiomers in urine

Biological Testing for Amphetamine and Methamphetamine Abuse

In this study, optimized methods are presented for sample preparation and chiral chromatography for the LC/MS analysis of amphetamine and methamphetamine enantiomers in urine.

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.